Study of a Brief Behavioral Intervention to Reduce Long-Term Use of Sleep Medication in People Age 60 and Older
Led by University Hospital, Akershus · Updated on 2024-11-15
120
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of a brief behavioral intervention delivered by trained general practitioners GPs to reduce the prolonged use of Z-hypnotic sleep medications among elderly patients in primary care. This randomized controlled trial compares this intervention to usual care provided by GPs without the specific training. The study focuses on elderly patients with harmful use of hypnotics, aiming to improve medication use and related outcomes.
Participants are randomly assigned to one of two groups an active group where GPs provide a short, structured behavioral intervention aimed at reducing inappropriate Z-hypnotics use, and a control group receiving usual care from GPs without this training. The controlled masked phase lasts 6 months, followed by an open single crossover where the control groups GPs receive the intervention training. Treatment effects are evaluated primarily 6 weeks after the intervention, with additional follow-ups at 6 and 12 months.
During the study, assessments include self-reported medication use, automatic sleep monitoring using actigraphy, cognitive function tests, pain scales, and sleep experience questionnaires. Baseline assessments focus on self-reports and actigraphy to minimize assessment effects. Follow-ups occur in person and by telephone, with blinded evaluators. The main outcome measured is inappropriate Z-hypnotics use 6 weeks after the intervention, with longer-term monitoring up to 12 months to assess lasting impacts.
CONDITIONS
Brief Title
Brief Intervention for Sleep Medication Misuse Among Elderly
Research Team
T
Tahreem G Siddiqui, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Self-reported use of Z-hypnotics more than 4 days per week and for more than 4 weeks
Age 60 years or older
You will not qualify if you...
Diagnosis of dementia
Diagnosis of psychosis
Diagnosis of major depression
Diagnosis of delirium
Unable to give informed consent
Insufficient Norwegian language capacity to complete tests
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Baseline Assessment
Duration - Up to 1 week
Participants complete self-reports and undergo automatic sleep assessment using actigraphy before intervention starts.
1 baseline visit (in-person) and actigraphy assessment
Brief Intervention or Business as Usual
Duration - 6 weeks
Participants receive either a brief behavioral intervention delivered by trained GPs to reduce inappropriate use of Z-hypnotics or continue with their usual care with untrained GPs.
1 to 2 visits depending on intervention arm
Follow-up Assessments
Duration - 6 months
Participants are assessed at 6 weeks and 6 months after intervention to evaluate sleep, cognitive function, and Z-hypnotics use, including in-person and telephone assessments.
1 in-person visit and some telephone assessments
Open Crossover and Long-term Follow-up
Duration - Up to 6 months
Participants initially in usual care receive the brief intervention after 6 months and are followed for up to 12 months to monitor long-term outcomes.
Periodic assessments during crossover phase
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
"What should I do when I get home?" treatment plan discussion at discharge between specialist physicians and older in-patients: mixed method study.
Association between prescribed central nervous system depressant drugs, comorbidity and cognition among hospitalised older patients: a cross-sectional study.
Tahreem Ghazal Siddiqui, Socheat Cheng, Michael Gossop...
Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial.
The effect of cognitive function and central nervous system depressant use on mortality-A prospective observational study of previously hospitalised older patients.
Tahreem Ghazal Siddiqui, Maria Torheim Bjelkarøy, Socheat Cheng...
Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial.